leukemia

137 проекта

HEИндивидуална стипендия2026–2029Германия

MPN2AML · Identification of novel genetic regulators governing leukaemic transformation from myeloid proliferative neoplasms

2 партньори · 2 държави

HEИндивидуална стипендия2026–2028Испания

NeutroMPN · Role of CD24 and CD24hi Neutrophils in key co-morbidities associated with the MyeloProliferative Neoplasms

2 партньори · 2 държави

HEИндивидуална стипендия2026–2028Белгия

RasWayToALL · Role of RAS mutant subclones in the development of High Hyperdiploid B-ALL

HEДокторантска мрежа2025–2029Испания

ACHILLES · Advancing in the CHallenge of Improving Lymphoma and LEukemia Survival

33 партньори · 12 държави

HEИндивидуална стипендия2025–2027Испания

RETRO · Relapse in T-ALL: Resistant Clones and Therapeutical Options

2 партньори

HEИндивидуална стипендия2025–2027Нидерландия

MarrowMimi · A bone marrow mimicry bioreactor for cost effective production of hematopoietic stem cells

HEИндивидуална стипендия2025–2026Нидерландия

SMART-AML · Shaping Marrow Adiposity to Redefine Treatment in Acute Myeloid Leukemia

HEДокторантска мрежа2024–2028Нидерландия

MIRACLE · Integrated multi-angle research and training network to eradicate leukemia minimal residual disease

22 партньори · 8 държави

HEИндивидуална стипендия2024–2027Нидерландия

BEAT B-cell Lymphoma · Biomarkers of Effective CART19 Assessed in the Tissue Microenvironment

2 партньори · 2 държави

HEИндивидуална стипендия2024–2026Белгия

PyroVector · Selective induction of PYROptosis in acute myeloid leukemia cells with VECTORized DPP9 inhibitors

HEСъфинансиране2024–2029Испания

CarrerasPathfinders · Enabling the next generation in search of blood cancer cures

47 партньори · 18 държави

HEИндивидуална стипендия2024–2026Испания

ChroMet · Elucidating the role of macroH2A1.2 histone variant as a metabolic sensor in the epigenetic regulation of leukaemia cell fate.

HEИндивидуална стипендия2023–2025Израел

PRELEUKMEC · Deciphering the intrinsic and extrinsic mechanisms shaping aging and leukemic evolution of hematopoietic stem cells at the single cell level

HEИндивидуална стипендия2023–2025Белгия

DPP9-TACDrug · DPP9 degradation-induced pyroptosis for treatment of acute myeloid leukemia

HEИндивидуална стипендия2023–2025Германия

MRDAML · Deciphering the mechanistic basis of minimal residual disease and treatment resistance in acute myeloid leukemia

HEИндивидуална стипендия2023–2024Испания

StemLinc · Identification and characterization of long non-coding RNAs as drivers of stemness in hematopoietic stem cells and leukemia.

HEИндивидуална стипендия2023–2026Испания

ALERT · Contribution of Lipid Droplets to the pathogenesis and chemoresistance of Acute Myeloid Leukemia

2 партньори

HEИндивидуална стипендия2022–2024Австрия

B-ALLeles · High resolution dissection of non-coding determinants of disease

2 партньори

HEИндивидуална стипендия2022–2024Германия

SESAHME · Spatially rEsolved Single-cell Approaches in Haematologic MalignanciEs

HEИндивидуална стипендия2022–2024Германия

engineereD to Clear · Investigation on the vaccination potential of IL4i1 deficient dendritic cells in Chronic lymphocytic leukemia

H2020Индивидуална стипендия2022–2024Германия

DIEAML · Deciphering immune evasion of Acute Myeloid Leukemia

H2020Индивидуална стипендия2022–2024Италия

BCRES-CLL · B cell receptor engagement and signalling in chronic lymphocytic leukemia: identify the structural and functional requirements for disease development and progression.

H2020Индивидуална стипендия2022–2024Австрия

AML-SynergyX · Systematic identification of genetic modifiers in the response to targeted therapies in acute myeloid leukemia.

H2020Индивидуална стипендия2022–2024Норвегия

SuccHSC · Succinate-induced leukemic stem cell formation via epigenetic remodeling of hematopoietic stem cell